Cleared Traditional

K913129 - ANGIOLAZ ANGIOSCOPE CATHETER

K913129 is an FDA 510(k) clearance for ANGIOLAZ ANGIOSCOPE CATHETER, manufactured by Angiolaz, Inc.. The device is a Class 2 Cardiovascular device with product code LYK cleared through the Traditional 510(k) pathway after a 164-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1991
Decision
164d
Days
Class 2
Risk

K913129 is an FDA 510(k) clearance for the ANGIOLAZ ANGIOSCOPE CATHETER. Classified as Angioscope (product code LYK), Class II - Special Controls.

Submitted by Angiolaz, Inc. (Rockingham, US). The FDA issued a Cleared decision on December 27, 1991 after a review of 164 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 876.1500 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K913129

510(k) Number K913129 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 16, 1991
Decision Date December 27, 1991
Days to Decision 164 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
39d slower than avg
Panel avg: 125d · This submission: 164d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LYK Device Classification - Class 2, Special Controls

Product Code LYK Angioscope
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LYK Angioscope

All 40
Devices cleared under the same product code (LYK) and FDA review panel - the closest regulatory comparables to K913129.
DISPOSABLE VASCULAR ANGIOSCOPE
K923996 · Endovascular, Inc. · Jan 1993
AMETEC MASY MODULAR ANGIOSCOPE SYSTEM
K905745 · American Medical Technology, Inc. · Apr 1992
DISPOSABLE VASCULAR ANGIOSCOPE
K914570 · Nobles-Lai · Jan 1992
INTERPRET(TM) CATHETER LINEAR TRANSLATOR
K913763 · Intertherapy, Inc. · Nov 1991
OMEGA ANGIOSCOPES (OMEGASCOPES)
K911090 · Omega Universal Technologies, Ltd. · Jul 1991
OLYMPUS AF ANGIOSCOPE SYSTEM
K911278 · Olympus Corp. · Jul 1991